NCT05960188

Brief Summary

One method of breast cancer screening involves radiologists reading digital tomosynthesis (DBT) images. DBT consists of a 3D stack of x-ray "slices" through the breast. The exam is accompanied by a 2D image like a standard mammogram, a single x-ray of the breast. In a screening setting, most cases are normal. Sometimes it is obvious that a case is normal from a quick look at the 2D image. It would speed up the process of screening if readers could dismiss a clearly normal case on the basis of the 2D image, alone, without looking at the DBT images. Obviously, the investigators would only want to "triage" cases in this way if the investigators were almost perfectly sure that no cancers would be missed. In this study, the investigators look at radiologist's willingness to triage cases and on the accuracy of their answers. In addition, the investigators ask about the impact of an Artificial Intelligence (AI) opinion. Would it be possible to triage an image on the basis of the AI opinion, alone? Radiologists will look at each case for up to five seconds and offer an opinion (on a 1-10 scale) about how sure they are that a case is normal. Next, they will see the opinion of the AI. Finally, they will say (using a 1-10) scale, how willing they would be for the AI to triage this case without human intervention. This study is the start of an effort to understand the conditions under which radiologists might be willing to declare a case "normal" with little or no human examination.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2023

Completed
3 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 4, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 4, 2023

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

July 14, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 25, 2023

Completed
Last Updated

December 11, 2025

Status Verified

December 1, 2025

Enrollment Period

3 days

First QC Date

July 14, 2023

Last Update Submit

December 4, 2025

Conditions

Keywords

MammographyDigital Breast TomosynthesisArtificial IntelligenceRadiologyMedical Image Perception

Outcome Measures

Primary Outcomes (2)

  • Abnormality rating accuracy

    Readers rate the abnormality of each image. The outcome measure is the agreement with gold standard truth for that case.

    through study completion, an average of 1 year

  • AI Acceptance rating

    Readers state if they would accept the AI rating as definitive. The relevant measure is the acceptance rate as a function of AI rating and the human rating of abnormality.

    through study completion, an average of 1 year

Interventions

AI OpinionBEHAVIORAL

For each case, we give the radiologist a numeric score reflecting the AI's rating of the abnormality of the case.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Must be Radiologists or radiology trainees
  • some experience reading mammography.

You may not qualify if:

  • acuity less than 20/25 with correction

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Visual Attention Lab / Brigham and Women's Hospital

Boston, Massachusetts, 02215, United States

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
At the end of the study, the participant is debriefed about their performance.
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: We are asking the opinions of a group of clinicians.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 14, 2023

First Posted

July 25, 2023

Study Start

March 1, 2023

Primary Completion

March 4, 2023

Study Completion

March 4, 2023

Last Updated

December 11, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will share

We share deidentified on request and, typically, on the Open Science Framework

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
We will post data on the OSF site at the end of the study and it will remain there indefinitely
Access Criteria
open, and we will also respond to requests.
More information

Locations